These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14965316)

  • 1. Interactions of HIV-1 proteins gp120 and Nef with cellular partners define a novel allosteric paradigm.
    Leavitt SA; SchOn A; Klein JC; Manjappara U; Chaiken IM; Freire E
    Curr Protein Pept Sci; 2004 Feb; 5(1):1-8. PubMed ID: 14965316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies.
    Pandey D; Podder A; Pandit M; Latha N
    J Biomol Struct Dyn; 2017 Sep; 35(12):2631-2644. PubMed ID: 27545652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
    Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
    J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication.
    Lundquist CA; Zhou J; Aiken C
    J Virol; 2004 Jun; 78(12):6287-96. PubMed ID: 15163722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4-binding obstacles in conformational transitions and allosteric communications of HIV gp120.
    Li Y; Guo YC; Zhang XL; Deng L; Sang P; Yang LQ; Liu SQ
    Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183217. PubMed ID: 32061646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of processed Nef (58-206) with virion proteins of HIV type 1.
    Ciuffi A; Munoz M; Bleiber G; Favre M; Stutz F; Telenti A; Meylan PR
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):399-407. PubMed ID: 15157358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of interactions between Nef and host cell proteins.
    Saksela K
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Dec; 4(4):315-9. PubMed ID: 15578982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive CD4 ligands as pre- and/or postbinding inhibitors of HIV-1.
    Briant L; Devaux C
    Adv Pharmacol; 2000; 48():373-407. PubMed ID: 10987097
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions of HIV-1 NEF with cellular signal transducing proteins.
    Renkema GH; Saksela K
    Front Biosci; 2000 Feb; 5():D268-83. PubMed ID: 10704155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein.
    Ross TM; Oran AE; Cullen BR
    Curr Biol; 1999 Jun; 9(12):613-21. PubMed ID: 10375525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.
    Dutartre H; Harris M; Olive D; Collette Y
    Virology; 1998 Aug; 247(2):200-11. PubMed ID: 9705913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef.
    Arold S; O'Brien R; Franken P; Strub MP; Hoh F; Dumas C; Ladbury JE
    Biochemistry; 1998 Oct; 37(42):14683-91. PubMed ID: 9778343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct in vitro binding of full-length human immunodeficiency virus type 1 Nef protein to CD4 cytoplasmic domain.
    Preusser A; Briese L; Baur AS; Willbold D
    J Virol; 2001 Apr; 75(8):3960-4. PubMed ID: 11264384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.
    Arold S; Franken P; Strub MP; Hoh F; Benichou S; Benarous R; Dumas C
    Structure; 1997 Oct; 5(10):1361-72. PubMed ID: 9351809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface down-modulation of CD4 after infection by HIV-1.
    Geleziunas R; Bour S; Wainberg MA
    FASEB J; 1994 Jun; 8(9):593-600. PubMed ID: 8005387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.
    Chazal N; Singer G; Aiken C; Hammarskjöld ML; Rekosh D
    J Virol; 2001 Apr; 75(8):4014-8. PubMed ID: 11264394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein.
    Arold ST; Baur AS
    Trends Biochem Sci; 2001 Jun; 26(6):356-63. PubMed ID: 11406408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells.
    Fackler OT; Wolf D; Weber HO; Laffert B; D'Aloja P; Schuler-Thurner B; Geffin R; Saksela K; Geyer M; Peterlin BM; Schuler G; Baur AS
    Curr Biol; 2001 Aug; 11(16):1294-9. PubMed ID: 11525746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the binding site of full length HIV-1 Nef on human Lck SH3 by NMR spectroscopy.
    Briese L; Preusser A; Willbold D
    J Biomed Sci; 2005; 12(3):451-6. PubMed ID: 15976924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells chronically infected with HIV do not contain sufficient Nef to promote CD4 downmodulation in the absence of envelope-mediated effects.
    Cucchiarini M; Barcellini-Couget S; Lefebvre JC; Doglio A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):112-9. PubMed ID: 9473011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.